To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ANKMY2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
279 supporting clones for gene ANKMY2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG700810 brain, hippocampus ANKMY2.a 1 to 692 7 to 698       698/698
(100 %)
5 diff
(99.3 %id)
BG703247 brain, hippocampus ANKMY2.a 1 to 785 7 to 784       784/795
(98 %)
22 diff
(97.3 %id)
NM_020319.2   ANKMY2.a 1 to 2547 3 to 2549 exact RefSeq, AAA   2549/2549
(100 %)
0 diff
(100 %id)
DA782471 brain ANKMY2.a 1 to 566 4 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
DA210027 brain ANKMY2.a 1 to 558 3 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
DA523642 brain ANKMY2.a 1 to 479 84 to 562   capped   480/561
(85 %)
8 diff
(98.6 %id)
DA742452   ANKMY2.a 1 to 396 3 to 402   capped   401/401
(100 %)
7 diff
(98.3 %id)
DB175021 kidney, tumor tissue ANKMY2.a 1 to 510 3 to 520   capped   519/520
(99 %)
9 diff
(98.3 %id)
DA167297 amygdala ANKMY2.a 1 to 579 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA290621 hippocampus ANKMY2.a 1 to 595 2 to 596   capped   595/597
(99 %)
3 diff
(99.5 %id)
DA344910 substantia nigra ANKMY2.a 1 to 563 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA365071 subthalamic nucleus ANKMY2.a 1 to 558 2 to 560   capped   559/559
(100 %)
3 diff
(99.5 %id)
DA393696 thalamus ANKMY2.a 1 to 583 2 to 584   tiling clone, capped   583/583
(100 %)
0 diff
(100 %id)
DA510686 brain ANKMY2.a 1 to 575 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DA514435 brain ANKMY2.a 1 to 551 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
DA520740 brain ANKMY2.a 1 to 566 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA525845 brain ANKMY2.a 1 to 274 2 to 275   capped   274/274
(100 %)
0 diff
(100 %id)
DA527152 brain ANKMY2.a 1 to 581 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
DA626663 Kidney ANKMY2.a 1 to 556 2 to 559   capped   558/559
(99 %)
3 diff
(99.5 %id)
DA707588   ANKMY2.a 1 to 577 2 to 581   capped   580/580
(100 %)
3 diff
(99.5 %id)
DA751875   ANKMY2.a 1 to 569 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA776230 brain ANKMY2.a 1 to 571 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA791281 brain ANKMY2.a 2 to 595 18 to 611   capped   594/594
(100 %)
1 diff
(99.9 %id)
DB093731 testis ANKMY2.a 2 to 512 38 to 548   capped   511/511
(100 %)
0 diff
(100 %id)
DA147952 amygdala ANKMY2.a 18 to 590 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DR002868 fetal brain ANKMY2.a 19 to 697 1 to 679       680/679
(100 %)
16 diff
(97.7 %id)
DA205575 brain ANKMY2.a 21 to 609 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA532941 brain ANKMY2.a 22 to 542 2 to 523   capped   522/522
(100 %)
1 diff
(99.9 %id)
DA198304 brain ANKMY2.a 27 to 586 2 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
DA295363 hippocampus ANKMY2.a 28 to 597 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA688887   ANKMY2.a 28 to 316 2 to 290   capped   289/289
(100 %)
0 diff
(100 %id)
AK001389   ANKMY2.a 29 to 2547 1 to 2518 G124D D342A K347R available from FLJ,   2518/2518
(100 %)
9 diff
(99.7 %id)
AU127279   ANKMY2.a 30 to 700 2 to 672   capped   671/671
(100 %)
5 diff
(99.3 %id)
TI_57148212   ANKMY2.a 33 to 723 22 to 716       695/836
(83 %)
15 diff
(98.3 %id)
BE871145 adenocarcinoma, colon ANKMY2.a 35 to 763 1 to 731       731/936
(78 %)
28 diff
(97.1 %id)
DA769520 brain ANKMY2.a 36 to 605 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BI918814 brain ANKMY2.a 37 to 745 23 to 737       715/767
(93 %)
29 diff
(96.3 %id)
TI_57241239   ANKMY2.a 37 to 745 23 to 737       715/767
(93 %)
29 diff
(96.3 %id)
DA149752 amygdala ANKMY2.a 39 to 605 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA524208 brain ANKMY2.a 39 to 600 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
DA772998 brain ANKMY2.a 39 to 621 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA285803 corpus callosum ANKMY2.a 40 to 529 2 to 492   capped   491/491
(100 %)
1 diff
(99.8 %id)
DA303826 hippocampus ANKMY2.a 40 to 598 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA500633 brain ANKMY2.a 40 to 613 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
BM789219 stomach ANKMY2.a 40 to 726 1 to 687       687/687
(100 %)
0 diff
(100 %id)
DB201027 trachea ANKMY2.a 40 to 628 2 to 590   capped   589/589
(100 %)
3 diff
(99.5 %id)
DA519726 brain ANKMY2.a 41 to 281 2 to 242   capped   241/241
(100 %)
0 diff
(100 %id)
DR001814 fetal brain ANKMY2.a 42 to 605 1 to 564       564/564
(100 %)
7 diff
(98.8 %id)
BC035353 Colon, Kidney, Stomach, adult, whole pooled ANKMY2.a 43 to 2547 1 to 2505 exact tiling clone, available from MGC, AAA   2505/2505
(100 %)
2 diff
(100.0 %id)
BI760286 pooled colon, kidney, stomach ANKMY2.a 43 to 723 1 to 686       686/806
(85 %)
10 diff
(98.8 %id)
DA500556 brain ANKMY2.a 50 to 595 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA024564   ANKMY2.a 52 to 641 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
AU122208.
matches multiple genes
mammary gland ANKMY2.a 52 to 751 2 to 698   capped also hits gene SUOX 697/706
(98 %)
12 diff
(98.4 %id)
BU933238 mixed (pool of 40 RNAs) ANKMY2.a 59 to 515 1 to 459       459/743
(61 %)
8 diff
(99.0 %id)
AK023704 placenta ANKMY2.a 62 to 2547 1 to 2486 C345R available from FLJ,   2486/2486
(100 %)
6 diff
(99.8 %id)
AL050390 brain ANKMY2.a 62 to 2547 5 to 2491 F274I P275S Y276L C277L E278* available from DKFZ, AAA   2487/2487
(100 %)
8 diff
(99.7 %id)
AU133350   ANKMY2.a 62 to 899 2 to 844   capped   843/848
(99 %)
13 diff
(98.5 %id)
DA155364 amygdala ANKMY2.a 63 to 615 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA663596   ANKMY2.a 63 to 635 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA708176   ANKMY2.a 63 to 612 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
AU139754 placenta ANKMY2.a 63 to 721 2 to 661   capped   660/662
(99 %)
6 diff
(99.1 %id)
DB180913 kidney, tumor tissue ANKMY2.a 63 to 629 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
BF183982 bone marrow, from chronic myelogenous leukemia ANKMY2.a 70 to 774 1 to 707       707/836
(84 %)
37 diff
(95.6 %id)
DA207307 brain ANKMY2.a 72 to 644 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA575999   ANKMY2.a 72 to 641 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DA176348 amygdala ANKMY2.a 73 to 590 2 to 522   capped   521/521
(100 %)
3 diff
(99.5 %id)
DA517369 brain ANKMY2.a 73 to 632 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DA691686   ANKMY2.a 73 to 658 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA784524 brain ANKMY2.a 73 to 595 2 to 525   capped   524/524
(100 %)
1 diff
(99.9 %id)
DB262922 uterus ANKMY2.a 73 to 595 2 to 525   capped   524/524
(100 %)
3 diff
(99.5 %id)
DB289249 uterus ANKMY2.a 73 to 632 2 to 562   capped   561/561
(100 %)
4 diff
(99.3 %id)
DB478293 hippocampus ANKMY2.a 74 to 562 1 to 489       489/489
(100 %)
0 diff
(100 %id)
BM147518 leukopheresis ANKMY2.a 81 to 586 1 to 506       506/506
(100 %)
16 diff
(96.9 %id)
CD696294 normal nasopharynx ANKMY2.a 82 to 554 18 to 490       473/490
(96 %)
7 diff
(98.6 %id)
CD700526 normal nasopharynx ANKMY2.a 82 to 591 25 to 534       510/534
(95 %)
6 diff
(98.9 %id)
AL548254 placenta, Placenta Cot 25-normalized ANKMY2.a 82 to 779 1 to 702       702/702
(100 %)
8 diff
(98.9 %id)
DN991381 brain, whole brain ANKMY2.a 83 to 736 32 to 687       654/687
(95 %)
12 diff
(98.3 %id)
DB008083 cervix, tumor tissue ANKMY2.a 83 to 644 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
DA716872   ANKMY2.a 85 to 626 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
BF030504 hypernephroma, Kidney ANKMY2.a 92 to 614 1 to 524       524/527
(99 %)
3 diff
(99.5 %id)
DA573252   ANKMY2.a 97 to 907 2 to 811   capped   810/811
(99 %)
8 diff
(99.1 %id)
DA794934 brain ANKMY2.a 98 to 741 2 to 645   capped   644/644
(100 %)
0 diff
(100 %id)
BE564194 bone marrow, from chronic myelogenous leukemia ANKMY2.a 101 to 773 1 to 675       675/791
(85 %)
21 diff
(97.4 %id)
DA208564 brain ANKMY2.a 104 to 669 2 to 569   capped   568/568
(100 %)
4 diff
(99.3 %id)
DA019926   ANKMY2.a 105 to 686 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DB110086 thymus ANKMY2.a 108 to 688 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DB218152 trachea ANKMY2.a 108 to 655 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB264483 uterus ANKMY2.a 109 to 668 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
AU099709   ANKMY2.a 110 to 408 1 to 299       299/300
(99 %)
15 diff
(95.0 %id)
DB054937 testis ANKMY2.a 113 to 668 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA043558 bladder ANKMY2.a 129 to 694 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
AA429832   ANKMY2.a 131 to 481 1 to 351       351/351
(100 %)
2 diff
(99.5 %id)
DB478946 hippocampus ANKMY2.a 132 to 614 1 to 483       483/483
(100 %)
3 diff
(99.4 %id)
DA712514   ANKMY2.a 136 to 711 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
CK823746 insulinoma, Pancreas ANKMY2.a 150 to 613 12 to 475       464/512
(90 %)
9 diff
(98.3 %id)
DN994299 brain, whole brain ANKMY2.a 151 to 684 9 to 544       534/544
(98 %)
11 diff
(98.0 %id)
DB242048 stomach, tumor tissue ANKMY2.a 153 to 719 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA042336 bladder ANKMY2.a 157 to 650 2 to 497   capped   496/496
(100 %)
4 diff
(99.2 %id)
DA043531 bladder ANKMY2.a 157 to 737 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA048461   ANKMY2.a 157 to 707 2 to 554   capped   553/553
(100 %)
5 diff
(99.1 %id)
DA472784   ANKMY2.a 157 to 634 2 to 479   capped   478/478
(100 %)
2 diff
(99.6 %id)
DA486358 brain ANKMY2.a 157 to 742 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DA621362 Kidney ANKMY2.a 157 to 717 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
BM504247 insulinoma, Pancreas ANKMY2.a 168 to 647 480 to 1       480/480
(100 %)
0 diff
(100 %id)
AL530515 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized ANKMY2.a 168 to 1254 1 to 1089       1089/1090
(99 %)
11 diff
(99.0 %id)
BM510789 insulinoma, Pancreas ANKMY2.a 168 to 647 480 to 1       480/481
(99 %)
0 diff
(100 %id)
DB114633 thymus ANKMY2.a 188 to 735 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
BU628095 Bone, Enchondroma cell line ANKMY2.a 199 to 929 13 to 743     Submitted on the opposite strand 731/731
(100 %)
0 diff
(100 %id)
DA210612 brain ANKMY2.a 200 to 479 2 to 281   capped   280/280
(100 %)
2 diff
(99.3 %id)
DB212080 trachea ANKMY2.a 200 to 742 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
AW958268   ANKMY2.a 210 to 657 1 to 448       448/583
(76 %)
1 diff
(99.9 %id)
AA310515   ANKMY2.a 223 to 656 1 to 435       435/435
(100 %)
1 diff
(99.8 %id)
DA281463 corpus callosum ANKMY2.a 229 to 777 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
CV029662 mixed ANKMY2.a 243 to 880 1 to 638       638/638
(100 %)
0 diff
(100 %id)
TI_1948129318   ANKMY2.a 243 to 985 132 to 890       759/1137
(66 %)
44 diff
(96.2 %id)
TI_1948129655   ANKMY2.a 243 to 788 130 to 675       546/1142
(47 %)
17 diff
(98.6 %id)
TI_1948130001   ANKMY2.a 243 to 772 130 to 665       536/1135
(47 %)
33 diff
(97.1 %id)
TI_1948130002   ANKMY2.a 243 to 875 125 to 761       637/1396
(45 %)
25 diff
(98.3 %id)
TI_1948130345   ANKMY2.a 243 to 772 127 to 663       537/1135
(47 %)
27 diff
(97.7 %id)
TI_1948130346   ANKMY2.a 243 to 1067 127 to 953       827/1321
(62 %)
35 diff
(97.4 %id)
TI_1948129656   ANKMY2.a 245 to 935 125 to 820       696/1335
(52 %)
34 diff
(97.5 %id)
BQ878863 dorsal root ganglia ANKMY2.a 279 to 1122 1 to 855       855/874
(97 %)
19 diff
(97.9 %id)
BU193889 melanotic melanoma, skin ANKMY2.a 307 to 1122 1 to 834       832/897
(92 %)
26 diff
(97.2 %id)
DA597898   ANKMY2.a 354 to 914 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
BG166276 hypernephroma, cell line, Kidney ANKMY2.a 411 to 1122 1 to 712       712/946
(75 %)
14 diff
(98.6 %id)
BP424589 small intestine ANKMY2.a 492 to 994 1 to 504     Submitted on the opposite strand 504/504
(100 %)
1 diff
(99.9 %id)
BQ946047 leiomyosarcoma, uterus ANKMY2.a 499 to 1382 1 to 885       887/931
(95 %)
13 diff
(98.7 %id)
BE539132 cervix ANKMY2.a 516 to 1225 1 to 716       714/913
(78 %)
34 diff
(96.3 %id)
DA678661   ANKMY2.a 567 to 1140 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
TI_57190870   ANKMY2.a 579 to 1281 54 to 754       701/701
(100 %)
2 diff
(99.8 %id)
BI857697 breast, mammary adenocarcinoma, cell line ANKMY2.a 581 to 1281 1 to 699       699/699
(100 %)
2 diff
(99.8 %id)
DA261192 caudate nucleus ANKMY2.a 619 to 1093 2 to 479   capped   478/479
(99 %)
8 diff
(98.4 %id)
BX369897 Placenta Cot 25-normalized ANKMY2.a 637 to 1066 1 to 435       435/497
(87 %)
29 diff
(94.2 %id)
BM144250 leukopheresis ANKMY2.a 658 to 1123 1 to 466       466/467
(99 %)
3 diff
(99.4 %id)
BM148436 leukopheresis ANKMY2.a 658 to 1109 1 to 453       453/453
(100 %)
3 diff
(99.4 %id)
BQ232674 melanotic melanoma, skin ANKMY2.a 665 to 1381 1 to 731       731/945
(77 %)
22 diff
(97.7 %id)
AA179225   ANKMY2.a 676 to 1199 1 to 523     Submitted on the opposite strand 523/524
(99 %)
11 diff
(98.0 %id)
BF241077 bone marrow, from acute myelogenous leukemia ANKMY2.a 767 to 1384 1 to 617       617/875
(70 %)
27 diff
(97.0 %id)
BG179389 adenocarcinoma, cell line, Prostate ANKMY2.a 777 to 1468 1 to 694       694/977
(71 %)
12 diff
(98.8 %id)
BF240774 bone marrow, from acute myelogenous leukemia ANKMY2.a 779 to 1321 1 to 545       541/1233
(43 %)
24 diff
(98.1 %id)
TI_1948130347   ANKMY2.a 798 to 1567 916 to 135       782/1371
(57 %)
50 diff
(96.4 %id)
CB156355 brain ANKMY2.a 809 to 1355 1 to 547       547/547
(100 %)
0 diff
(100 %id)
TI_1948129658   ANKMY2.a 860 to 1567 827 to 126       704/1058
(66 %)
50 diff
(95.3 %id)
DA700812   ANKMY2.a 870 to 1371 2 to 503   capped   502/502
(100 %)
1 diff
(99.9 %id)
BG779719 adenocarcinoma, Prostate ANKMY2.a 913 to 1592 18 to 696       679/698
(97 %)
14 diff
(98.0 %id)
BG500864 adenocarcinoma, Prostate ANKMY2.a 980 to 1740 1 to 771       771/772
(99 %)
23 diff
(97.1 %id)
BF732736 fibrotheoma, ovary ANKMY2.a 989 to 1366 380 to 3       378/424
(89 %)
4 diff
(99.1 %id)
BC015453 Prostate, adenocarcinoma. ANKMY2.a 1081 to 2547 1 to 1467   tiling clone, available from MGC, AAA   1467/1467
(100 %)
0 diff
(100 %id)
BG181160 adenocarcinoma, cell line, Prostate ANKMY2.a 1089 to 1795 1 to 697   available from MGC,   697/946
(73 %)
25 diff
(97.4 %id)
DB458020 testis ANKMY2.a 1174 to 1687 1 to 514       514/514
(100 %)
3 diff
(99.5 %id)
CR598118 fetal brain ANKMY2.a 1213 to 2512 1 to 1300       1300/1300
(100 %)
0 diff
(100 %id)
AL538871 brain, fetal brain ANKMY2.a 1213 to 1624 1 to 421   fully sequenced,   421/421
(100 %)
16 diff
(96.2 %id)
BM829611 stomach ANKMY2.a 1228 to 1731 1 to 504       504/504
(100 %)
16 diff
(96.9 %id)
BU660713 blood ANKMY2.a 1264 to 1769 11 to 516       506/516
(98 %)
10 diff
(98.1 %id)
DB523513 testis ANKMY2.a 1272 to 1709 1 to 438     Submitted on the opposite strand 438/438
(100 %)
2 diff
(99.6 %id)
BX098220 liver and spleen ANKMY2.a 1281 to 2043 1 to 763       763/763
(100 %)
2 diff
(99.8 %id)
T83069 liver and spleen ANKMY2.a 1281 to 1634 1 to 363       363/427
(85 %)
11 diff
(97.5 %id)
R94310 liver and spleen ANKMY2.a 1281 to 1652 1 to 377       377/382
(98 %)
19 diff
(95.1 %id)
DB508695 testis ANKMY2.a 1287 to 1709 1 to 422     Submitted on the opposite strand 422/422
(100 %)
4 diff
(99.1 %id)
AA486805 lung ANKMY2.a 1305 to 1703 1 to 398       398/398
(100 %)
4 diff
(99.0 %id)
BF673718 Prostate ANKMY2.a 1333 to 1981 1 to 649       649/891
(72 %)
25 diff
(97.2 %id)
BM857376 stomach ANKMY2.a 1333 to 1728 1 to 396       396/396
(100 %)
2 diff
(99.5 %id)
CD245462 White Matter ANKMY2.a 1335 to 2123 1 to 794       794/923
(86 %)
41 diff
(95.6 %id)
BM704156 eye, Retina Foveal and Macular ANKMY2.a 1377 to 1846 1 to 470       470/470
(100 %)
7 diff
(98.6 %id)
BM851547 stomach ANKMY2.a 1384 to 1892 1 to 509       509/509
(100 %)
3 diff
(99.5 %id)
AL530514 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized ANKMY2.a 1387 to 2531 1141 to 1       1141/1141
(100 %)
33 diff
(97.2 %id)
BE567731 bladder, carcinoma, cell line ANKMY2.a 1408 to 2086 1 to 666       666/880
(75 %)
36 diff
(96.0 %id)
BG254536 adenocarcinoma, cell line, Prostate ANKMY2.a 1431 to 2163 1 to 744       744/1031
(72 %)
32 diff
(96.9 %id)
BX371603 Placenta Cot 25-normalized ANKMY2.a 1438 to 1977 589 to 47       543/903
(60 %)
0 diff
(100 %id)
AA102001 colon, tumor ANKMY2.a 1443 to 1835 15 to 411       397/411
(96 %)
6 diff
(98.6 %id)
CA394330 eye, RPE/choroid ANKMY2.a 1445 to 2175 1 to 731       731/731
(100 %)
2 diff
(99.8 %id)
AA326507 brain, cerebellum ANKMY2.a 1450 to 1881 1 to 435       435/435
(100 %)
7 diff
(98.4 %id)
AW964960   ANKMY2.a 1451 to 1986 1 to 536       536/536
(100 %)
5 diff
(99.1 %id)
BM930568 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid ANKMY2.a 1456 to 1804 1 to 349       349/350
(99 %)
5 diff
(98.6 %id)
DA009422 adrenal gland ANKMY2.a 1523 to 2077 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
TI_153955714   ANKMY2.a 1552 to 2078 86 to 611       526/526
(100 %)
72 diff
(86.4 %id)
BQ011390 placenta ANKMY2.a 1561 to 2016 474 to 19   AAA   456/456
(100 %)
3 diff
(99.4 %id)
AL567534 brain, fetal brain ANKMY2.a 1594 to 2512 918 to 1   fully sequenced,   918/918
(100 %)
6 diff
(99.4 %id)
AI376655 pooled ANKMY2.a 1599 to 2017 421 to 3       419/421
(99 %)
0 diff
(100 %id)
BF028457 bladder, carcinoma, cell line ANKMY2.a 1636 to 2348 1 to 708       708/1074
(65 %)
33 diff
(97.0 %id)
BG426333 Kidney ANKMY2.a 1638 to 2500 1 to 872       872/885
(98 %)
48 diff
(94.6 %id)
TI_159700404   ANKMY2.a 1649 to 2544 958 to 81   AAA   878/962
(91 %)
30 diff
(96.9 %id)
CB054472 brain, glioblastoma (pooled) ANKMY2.a 1660 to 2002 10 to 353   fully sequenced,   344/353
(97 %)
7 diff
(98.1 %id)
CD000777 Pooled-Skin ANKMY2.a 1704 to 2382 1 to 688       688/759
(90 %)
18 diff
(97.7 %id)
TI_149272026   ANKMY2.a 1785 to 2551 845 to 86   AAA   760/961
(79 %)
34 diff
(96.5 %id)
TI_154044450   ANKMY2.a 1796 to 2547 828 to 84   AAA   745/902
(82 %)
19 diff
(97.9 %id)
TI_154060340   ANKMY2.a 1818 to 2553 850 to 122       729/1030
(70 %)
0 diff
(100 %id)
CA418922 Chondrosarcoma Grade II, Left Pelvis ANKMY2.a 1827 to 2547 739 to 19   AAA   721/721
(100 %)
1 diff
(99.9 %id)
BQ688011 ductal carcinoma, cell line, Pancreas ANKMY2.a 1875 to 2383 516 to 8     Submitted on the opposite strand 509/882
(57 %)
0 diff
(100 %id)
CA429094 Cell Line, Chondrosarcoma ANKMY2.a 1876 to 2547 690 to 19   AAA   672/672
(100 %)
2 diff
(99.8 %id)
W79602 heart ANKMY2.a 1884 to 2255 1 to 381   fully sequenced,   381/381
(100 %)
11 diff
(97.2 %id)
BF365813 nervous_tumor ANKMY2.a 1895 to 2288 406 to 13       394/406
(97 %)
0 diff
(100 %id)
AW881102 ovary ANKMY2.a 1917 to 2182 13 to 278       266/278
(95 %)
6 diff
(97.9 %id)
AW890978 nervous_tumor ANKMY2.a 1918 to 2288 1 to 373       373/373
(100 %)
3 diff
(99.2 %id)
TI_149283341   ANKMY2.a 1926 to 2547 699 to 80   AAA   620/710
(87 %)
2 diff
(99.8 %id)
BM984023 lung, Primary Lung Epithelial Cells ANKMY2.a 1926 to 2547 636 to 17   AAA   620/633
(97 %)
2 diff
(99.7 %id)
CB159320 Liver ANKMY2.a 1951 to 2437 1 to 487       487/487
(100 %)
0 diff
(100 %id)
CB054471 brain, glioblastoma (pooled) ANKMY2.a 1972 to 2547 618 to 44   fully sequenced, AAA   575/575
(100 %)
1 diff
(99.9 %id)
AW295396   ANKMY2.a 1974 to 2547 591 to 18   AAA   574/574
(100 %)
1 diff
(99.9 %id)
AU158160 placenta ANKMY2.a 1976 to 2547 570 to 1       570/571
(99 %)
19 diff
(96.7 %id)
CA411770 Chondrosarcoma Grade II, Left Pelvis ANKMY2.a 1980 to 2547 586 to 19   AAA   568/568
(100 %)
0 diff
(100 %id)
BU674794 lung, Primary Lung Epithelial Cells ANKMY2.a 1988 to 2551 578 to 15   AAA   564/564
(100 %)
6 diff
(99.0 %id)
AU154704   ANKMY2.a 1996 to 2547 547 to 1       547/563
(97 %)
12 diff
(97.9 %id)
AA487127 lung ANKMY2.a 2139 to 2549 411 to 1       411/411
(100 %)
2 diff
(99.6 %id)
BU730047 eye, Retina Foveal and Macular ANKMY2.a 2156 to 2547 408 to 17   AAA   392/392
(100 %)
0 diff
(100 %id)
R94214 liver and spleen ANKMY2.a 2157 to 2549 400 to 2       399/400
(99 %)
0 diff
(100 %id)
T90534 liver and spleen ANKMY2.a 2188 to 2540 361 to 1       361/505
(71 %)
9 diff
(98.3 %id)
AA446258   ANKMY2.a 2202 to 2547 346 to 1       346/346
(100 %)
1 diff
(99.8 %id)
W79503 heart ANKMY2.a 2225 to 2552 331 to 1   fully sequenced,   331/331
(100 %)
3 diff
(99.1 %id)
T99234 liver and spleen ANKMY2.a 2236 to 2522 292 to 1       292/382
(76 %)
6 diff
(98.5 %id)
AL572887 placenta, Placenta Cot 25-normalized ANKMY2.a 2245 to 2496 274 to 23       765/861
(88 %)
6 diff
(99.4 %id)
AI651037 Kidney ANKMY2.a 2269 to 2553 288 to 4       285/288
(98 %)
0 diff
(100 %id)
AA742203 germinal center B cell ANKMY2.a 2276 to 2547 296 to 25   AAA   272/272
(100 %)
0 diff
(100 %id)
AA810153 germinal center B cell ANKMY2.a 2278 to 2547 331 to 62   AAA   270/270
(100 %)
0 diff
(100 %id)
F02001 brain, total brain ANKMY2.a 2285 to 2547 263 to 1       263/263
(100 %)
0 diff
(100 %id)
G31741   ANKMY2.a 2285 to 2547 263 to 1     Submitted on the opposite strand 263/263
(100 %)
0 diff
(100 %id)
AA099492 colon, tumor ANKMY2.a 2290 to 2531 243 to 1       243/286
(84 %)
3 diff
(99.0 %id)
DW437793 Liver ANKMY2.a 2299 to 2522 17 to 240       224/247
(90 %)
2 diff
(99.2 %id)
N67906 cochlea, ear ANKMY2.a 2317 to 2553 238 to 2       237/238
(99 %)
0 diff
(100 %id)
AW023586 cochlea, ear ANKMY2.a 2330 to 2547 8 to 225   AAA   218/225
(96 %)
6 diff
(97.4 %id)
AA953263 2 pooled tumors (clear cell type), Kidney ANKMY2.a 2344 to 2551 208 to 1       208/208
(100 %)
0 diff
(100 %id)
AI868104 poorly differentiated adenocarcinoma withsignet ring cell features, stomach ANKMY2.a 2350 to 2547 209 to 12   AAA   198/198
(100 %)
0 diff
(100 %id)
AK001740   ANKMY2.b 1 to 2598 2 to 2599 D151G F319L tiling clone, available from FLJ,   2599/2599
(100 %)
7 diff
(99.8 %id)
AA702804 liver and spleen ANKMY2.b 2076 to 2592 517 to 1       517/517
(100 %)
2 diff
(99.7 %id)
AI820095 pooled ANKMY2.b 2091 to 2598 509 to 1       509/509
(100 %)
6 diff
(98.9 %id)
AI090861   ANKMY2.b 2097 to 2601 506 to 2       505/506
(99 %)
0 diff
(100 %id)
BP397943 pancreatic islet ANKMY2.b 2099 to 2598 1 to 500     Submitted on the opposite strand 500/500
(100 %)
1 diff
(99.8 %id)
DB546938 hippocampus ANKMY2.b 2118 to 2598 5 to 485   AAA Submitted on the opposite strand 481/485
(99 %)
6 diff
(98.8 %id)
AI190445 heart ANKMY2.b 2118 to 2602 485 to 1       485/485
(100 %)
1 diff
(99.8 %id)
CF129659 Chondrosarcoma Lung Metastasis cell lines, lung ANKMY2.b 2122 to 2598 1 to 476   AAA   476/476
(100 %)
1 diff
(99.8 %id)
TI_154191407   ANKMY2.b 2122 to 2598 51 to 526   AAA   476/476
(100 %)
1 diff
(99.8 %id)
AW662073 2 pooled high-grade transitional celltumors, genitourinary tract ANKMY2.b 2136 to 2601 466 to 1       466/466
(100 %)
1 diff
(99.8 %id)
AI979253 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors ANKMY2.b 2140 to 2598 459 to 1       459/459
(100 %)
2 diff
(99.6 %id)
AJ711006 heart ANKMY2.b 2150 to 2598 21 to 469   AAA   449/469
(95 %)
6 diff
(98.8 %id)
BE673505 Prostate ANKMY2.b 2153 to 2600 448 to 1       448/448
(100 %)
1 diff
(99.8 %id)
TI_151732836   ANKMY2.b 2159 to 2598 524 to 85   AAA   440/979
(44 %)
2 diff
(99.8 %id)
BQ186936 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid ANKMY2.b 2162 to 2598 1 to 437   fully sequenced, AAA   437/437
(100 %)
1 diff
(99.8 %id)
DB547611 hippocampus ANKMY2.b 2165 to 2596 1 to 432     Submitted on the opposite strand 432/434
(99 %)
2 diff
(99.6 %id)
AW467135 2 pooled tumors (clear cell type), Kidney ANKMY2.b 2183 to 2596 418 to 5       414/418
(99 %)
0 diff
(100 %id)
N62320 multiple sclerosis lesions ANKMY2.b 2184 to 2598 416 to 1       416/416
(100 %)
1 diff
(99.8 %id)
AI887185 serous papillary carcinoma, high grade, 2pooled tumors, uterus ANKMY2.b 2184 to 2598 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AI560092 poorly differentiated adenocarcinoma withsignet ring cell features, stomach ANKMY2.b 2191 to 2601 412 to 2       411/412
(99 %)
0 diff
(100 %id)
AW976202   ANKMY2.b 2201 to 2597 397 to 1     Submitted on the opposite strand 397/397
(100 %)
18 diff
(95.5 %id)
R15646   ANKMY2.b 2205 to 2475 271 to 1       271/272
(99 %)
2 diff
(99.3 %id)
AA749359 germinal center B cell ANKMY2.b 2205 to 2598 418 to 25   AAA   394/394
(100 %)
0 diff
(100 %id)
AA767209 germinal center B cell ANKMY2.b 2205 to 2598 417 to 24   AAA   394/394
(100 %)
1 diff
(99.8 %id)
BM144607 leukopheresis ANKMY2.b 2209 to 2604 414 to 19   tiling clone,   396/414
(95 %)
0 diff
(100 %id)
BQ002231 Chondrosarcoma, Left Pelvis ANKMY2.b 2247 to 2598 370 to 19   AAA   352/352
(100 %)
4 diff
(98.9 %id)
AI247517 liver and spleen ANKMY2.b 2263 to 2599 337 to 1       337/337
(100 %)
1 diff
(99.8 %id)
AA889045 pooled ANKMY2.b 2272 to 2598 340 to 14   AAA   327/327
(100 %)
0 diff
(100 %id)
AI768905 Kidney ANKMY2.b 2273 to 2601 330 to 2       329/330
(99 %)
0 diff
(100 %id)
AA652513   ANKMY2.b 2282 to 2596 328 to 14   AAA   315/315
(100 %)
1 diff
(99.7 %id)
CN357950 embryonic stem cells, DMSO-treated H9 cellline ANKMY2.b 2286 to 2589 5 to 308       304/308
(98 %)
10 diff
(96.8 %id)
CK300019 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid ANKMY2.b 2464 to 2598 151 to 17   fully sequenced, AAA   135/135
(100 %)
0 diff
(100 %id)
AL541077 placenta ANKMY2.c 1 to 985 1 to 985   tiling clone,   985/985
(100 %)
2 diff
(99.8 %id)
U46340 liver cell line, pancreatic cancer ANKMY2.c 530 to 899 1 to 375       375/375
(100 %)
6 diff
(98.4 %id)
AL568722 placenta ANKMY2.c 1328 to 2085 906 to 160       747/923
(80 %)
0 diff
(100 %id)
BM791635 stomach ANKMY2.c 1590 to 2291 1 to 702   tiling clone,   702/702
(100 %)
0 diff
(100 %id)
CN357951 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 ANKMY2.d 1 to 684 1 to 685 exact tiling clone,   685/685
(100 %)
3 diff
(99.6 %id)
DB260055 uterus ANKMY2.d 77 to 665 2 to 590 exact capped   589/589
(100 %)
3 diff
(99.5 %id)
DW422910 Liver ANKMY2.d 369 to 646 16 to 293       278/293
(94 %)
6 diff
(98.0 %id)
DW420948 Liver ANKMY2.d 461 to 743 17 to 299   tiling clone,   283/299
(94 %)
11 diff
(96.4 %id)
DW433254 Liver ANKMY2.d 461 to 707 17 to 263   tiling clone,   247/263
(93 %)
6 diff
(97.8 %id)
DB268802 uterus ANKMY2.e 1 to 586 2 to 587 exact tiling clone, capped   586/586
(100 %)
0 diff
(100 %id)
DA526311 brain ANKMY2.f 1 to 570 2 to 571 V48A capped   570/570
(100 %)
1 diff
(99.9 %id)
DA661476   ANKMY2.f 1 to 590 2 to 591 exact tiling clone, capped   590/590
(100 %)
0 diff
(100 %id)
DB103830 thymus ANKMY2.f 41 to 621 2 to 583 Y74C tiling clone, capped   582/582
(100 %)
2 diff
(99.7 %id)
DB136806 thymus ANKMY2.g 1 to 487 2 to 488 exact tiling clone, capped   487/487
(100 %)
0 diff
(100 %id)
DA514150 brain ANKMY2.g 362 to 917 2 to 558   tiling clone, capped   557/557
(100 %)
2 diff
(99.7 %id)
DA945079 Spleen ANKMY2.g 507 to 1067 2 to 562   tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
BG430401 Kidney ANKMY2.g 725 to 1511 1 to 783       783/808
(96 %)
33 diff
(96.0 %id)
BY799286 eye ANKMY2.g 1062 to 1663 1 to 602   tiling clone,   602/602
(100 %)
1 diff
(99.9 %id)
BQ694547 adipose ANKMY2.g 1133 to 1505 1 to 369       369/375
(98 %)
13 diff
(96.6 %id)
H64123 liver and spleen ANKMY2.g 1300 to 1764 9 to 486       478/486
(98 %)
5 diff
(99.0 %id)
Z44891 brain, total brain ANKMY2.g 1349 to 1625 1 to 277       277/277
(100 %)
0 diff
(100 %id)
T85888 liver and spleen ANKMY2.g 1616 to 1880 1 to 277   tiling clone,   277/300
(92 %)
22 diff
(92.7 %id)
BG620300 placenta ANKMY2.g 1685 to 2508 1 to 822   tiling clone,   822/822
(100 %)
20 diff
(97.6 %id)
FN114918 breast carcinoma ANKMY2.g 1701 to 1782 1 to 83       83/83
(100 %)
3 diff
(96.4 %id)
CX786921 human embryonic stem cells ANKMY2.g 1738 to 2520 8 to 790   tiling clone,   783/790
(99 %)
6 diff
(99.3 %id)
DB316675 brain ANKMY2.g 2389 to 2920 532 to 1   tiling clone,   532/532
(100 %)
0 diff
(100 %id)
H64170 liver and spleen ANKMY2.g 2558 to 2920 389 to 1       389/390
(99 %)
30 diff
(92.4 %id)
T90883 liver and spleen ANKMY2.g 2561 to 2912 360 to 2       359/367
(97 %)
0 diff
(100 %id)
Z40659 brain, total brain ANKMY2.g 2638 to 2924 287 to 1   tiling clone,   287/287
(100 %)
0 diff
(100 %id)
DA166601 amygdala ANKMY2.h-u 1 to 565 2 to 566 exact tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
BM928403 brain ANKMY2.h-u 175 to 1074 1 to 906   tiling clone,   906/1073
(84 %)
21 diff
(98.1 %id)
CN304208 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 ANKMY2.h-u 842 to 1561 1 to 719   tiling clone,   719/719
(100 %)
1 diff
(99.9 %id)
CR735736   ANKMY2.h-u 892 to 1236 1 to 345   tiling clone,   345/345
(100 %)
0 diff
(100 %id)
DB302436 amygdala ANKMY2.h-u 1411 to 1946 538 to 1   tiling clone,   538/538
(100 %)
5 diff
(99.1 %id)
AA643238 lymph node, lymphoma ANKMY2.h-u 1470 to 1943 476 to 2       475/476
(99 %)
0 diff
(100 %id)
AI276540 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ANKMY2.h-u 1504 to 1943 442 to 3   tiling clone,   440/442
(99 %)
0 diff
(100 %id)
AA554217 colon ANKMY2.h-u 1634 to 1942 309 to 1       309/309
(100 %)
0 diff
(100 %id)
BG539010 lung ANKMY2.i-u 1 to 721 1 to 714 exact tiling clone,   714/891
(80 %)
20 diff
(97.8 %id)
BX497167 Liver ANKMY2.i-u 269 to 709 1 to 441   tiling clone,   441/441
(100 %)
3 diff
(99.4 %id)
DA655825   ANKMY2.j-u 1 to 564 2 to 568 exact tiling clone, capped   567/567
(100 %)
4 diff
(99.3 %id)
N23377 melanocyte Gene ANKMY2, variant not shown         This clone was ignored    
N32358 melanocyte Gene ANKMY2, variant not shown         This clone was ignored    
BF980754 duodenal adenocarcinoma, cell line, small intestine Gene ANKMY2, variant not shown         This clone was ignored    
DB164175 thymus Gene ANKMY2, variant not shown       capped This clone was ignored    
DB240726 trachea Gene ANKMY2, variant not shown       capped This clone was ignored    
DB350589 trachea Gene ANKMY2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i-u, .j-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C